Citius Pharma earnings missed by $0.37, revenue fell short of estimates — See source for full details.
$CTXR
Price history, market instrument context, member research, and related headlines in one place.
CTXR key statistics
NasdaqCMUSD
52-week range
$0.451%$2.19
Latest session $0.45–$0.47Citius Pharmaceuticals, Inc. (CTXR) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $0.465, down $0.01 (2.31%) from the previous close of $0.476. It has traded between $0.45 and $0.47 in the latest session. Over the past year it has ranged from $0.45 to $2.19, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 233.6K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M — See source for full details.
Loading $CTXR research…